-
281
-
282
Cancer-associated fibroblasts as therapeutic targets for cancer: advances, challenges, and future prospects
Published 2025-01-01Get full text
Article -
283
Two Cases of Ectopic Hamartomatous Thymoma Masquerading as Sarcoma
Published 2017-01-01Get full text
Article -
284
-
285
-
286
-
287
-
288
Personalized allele-specific antisense oligonucleotides for GNAO1-neurodevelopmental disorder
Published 2025-03-01Get full text
Article -
289
-
290
Novel In Vitro Assays for the Characterization of EMT in Tumourigenesis
Published 2010-01-01Get full text
Article -
291
Long-Term Survival and PSA Control with Radiation and Immunotherapy for Node Positive Prostate Cancer
Published 2009-01-01Get full text
Article -
292
-
293
-
294
-
295
miR‐130a‐3p regulated TGF‐β1‐induced epithelial‐mesenchymal transition depends on SMAD4 in EC‐1 cells
Published 2019-03-01Get full text
Article -
296
D-2-hydroxyglutarate impairs DNA repair through epigenetic reprogramming
Published 2025-02-01Get full text
Article -
297
Exploring PANoptosis in head and neck cancer: A novel approach to cancer therapy
Published 2025-01-01“…PANoptosis is a newly discovered complex programmed cell death (PCD) form. In the field of cancer research, PANoptosis is involved in multiple cell death pathways that affect tumor cell survival, proliferation, and response to treatment, serving as an innovative strategy for cancer therapy. …”
Get full text
Article -
298
Centrosome amplification and aneuploidy driven by the HIV-1-induced Vpr•VprBP•Plk4 complex in CD4+ T cells
Published 2024-03-01Get full text
Article -
299
Predicting immunotherapy efficacy in endometrial cancer: focus on the tumor microenvironment
Published 2025-01-01Get full text
Article -
300
Robust and inducible genome editing via an all-in-one prime editor in human pluripotent stem cells
Published 2024-12-01Get full text
Article